News

CGT-funded research shows resistant breast cancer in mice cured 60-90 percent with combination of two immunotherapies: Oncolytic viruses and checkpoint inhibitors
| 3 min read

CGT-funded research shows resistant breast cancer in mice cured 60-90 percent with combination of two immunotherapies: Oncolytic viruses and checkpoint inhibitors